Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients

Eur Neuropsychopharmacol. 2011 Apr;21(4):294-9. doi: 10.1016/j.euroneuro.2010.06.006. Epub 2010 Jul 8.

Abstract

Previously one intronic DRD3 SNP, rs167771, was associated with risperidone-induced extrapyramidal side-effects (EPS). The aim of the present study was to search hitherto unidentified common functional variants or rare variants, in DRD3 associated with risperidone-induced EPS. 126 subjects treated with risperidone participated in this study. We sequenced the seven exons of DRD3. After sequencing we localized five dbSNPs and four new rare variants. None of the dSNPs or rare variants seems to be functional after bioinformatics analysis. Our results suggest that, rather than exonic regions, regulatory regions and introns could be related to the associations reported for DRD3 and the incidence of locomotor side-effects.

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Basal Ganglia Diseases / chemically induced
  • Basal Ganglia Diseases / genetics*
  • Case-Control Studies
  • Cohort Studies
  • Diagnostic and Statistical Manual of Mental Disorders
  • Dopamine Antagonists / adverse effects*
  • Dopamine Antagonists / therapeutic use
  • Exons*
  • Female
  • Genetic Association Studies
  • Genetic Variation*
  • Humans
  • Male
  • Mutation
  • Polymorphism, Single Nucleotide
  • Psychotic Disorders / drug therapy
  • Psychotic Disorders / genetics
  • Receptors, Dopamine D3 / genetics*
  • Risperidone / adverse effects*
  • Risperidone / therapeutic use
  • Spain
  • Young Adult

Substances

  • Antipsychotic Agents
  • DRD3 protein, human
  • Dopamine Antagonists
  • Receptors, Dopamine D3
  • Risperidone